The Current Ratio as of December 2025 (TTM) for LAUNXP Biomedical Co., Ltd (6876.TWO) is 7.53

According to LAUNXP Biomedical Co., Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 7.53. This represents a change of -27.32% compared to the average of 10.36 of the last 4 quarters.

LAUNXP Biomedical Co., Ltd (6876.TWO) Historical Current Ratio (quarterly & annually)

How has 6876.TWO Current Ratio performed in the past?

The mean historical Current Ratio of LAUNXP Biomedical Co., Ltd over the last ten years is 7.70. The current 7.53 Current Ratio has changed 9.68% with respect to the historical average. Over the past ten years (40 quarters), 6876.TWO's Current Ratio was at its highest in in the June 2022 quarter at 19.44. The Current Ratio was at its lowest in in the December 2022 quarter at 3.20.

LAUNXP Biomedical Co., Ltd (6876.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of LAUNXP Biomedical Co., Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

LAUNXP Biomedical Co., Ltd (6876.TWO) Average Current Ratio

How has 6876.TWO Current Ratio performed in the past?

The current Current Ratio of LAUNXP Biomedical Co., Ltd (6876.TWO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

LAUNXP Biomedical Co., Ltd (6876.TWO) Current Ratio vs. Peers

How is 6876.TWO’s Current Ratio compared to its peers?

LAUNXP Biomedical Co., Ltd’s Current Ratio is less than LabTurbo Biotech Corporation (14.89), less than Bio Preventive Medicine Corp. (19.06), greater than Lukas Biomedical Inc. (1.21), greater than MegaPro Biomedical Co., Ltd (4.34), less than Andros Pharmaceuticals Co.,Ltd (13.81), greater than Level Biotechnology Inc. (1.93), greater than TCI GENE Inc. (5.74), less than NatureWise Biotech & Medicals Corporation (11.89), less than SynCore Biotechnology Co.,Ltd (11.18), less than Eusol Biotech Co.,Ltd. (43.56),

Build a custom stock screener for LAUNXP Biomedical Co., Ltd (6876.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LAUNXP Biomedical Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

LAUNXP Biomedical Co., Ltd (6876.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like LAUNXP Biomedical Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.